Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma

Background: The systemic immune-inflammation index (SII) has been reported to be associated with patient survival in various kinds of solid tumors. However, just few studies have focused on its prognostic value in patients with surgically resected esophageal squamous cell carcinoma (ESCC). Materials...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yibo, Guo, Wei, Cai, Songhua, Zhang, Fan, Shao, Fei, Zhang, Guochao, Liu, Tiejun, Tan, Fengwei, Li, Ning, Xue, Qi, Gao, Shugeng, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603384/
https://www.ncbi.nlm.nih.gov/pubmed/31289589
http://dx.doi.org/10.7150/jca.30281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603384/
https://www.ncbi.nlm.nih.gov/pubmed/31289589
http://dx.doi.org/10.7150/jca.30281

Ejemplares similares